Callio raised $187M in a series A funding round to advance its biopharma initiatives.
03/03/25, 11:27 PM
Money raised
$187 million
Round Type
series a
Callio completed a $187 million series A funding round, contributing to the trend of increasing venture capital funding within the biopharma sector in 2024. This round reflects a portion of the $25.3 billion raised by biopharmaceutical companies as reported by the NVCA.